FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer
Condition(s):Non-small Cell Lung Cancer (NSCLC)Last Updated:November 15, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung Cancer (NSCLC)Last Updated:November 15, 2022Completed
Condition(s):Non Small Cell Lung Cancer; Lung CancerLast Updated:February 28, 2024Terminated
Condition(s):Colorectal Cancer; Metastatic CancerLast Updated:March 5, 2013Completed
Condition(s):LeukemiaLast Updated:June 24, 2013Completed
Condition(s):Cutaneous Melanoma; Melanoma; Melanoma of Unknown Primary; Mucosal Melanoma; Ocular Melanoma; Stage IIB Cutaneous Melanoma AJCC v6 and v7; Stage IIC Cutaneous Melanoma AJCC v6 and v7; Stage III Cutaneous Melanoma AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7Last Updated:November 16, 2021Completed
Condition(s):Kidney Cancer; Melanoma (Skin)Last Updated:April 30, 2015Completed
Condition(s):Metastatic Triple Negative Breast CancerLast Updated:June 22, 2023Recruiting
Condition(s):Stage IV Melanoma; Stage IV Renal Cell Cancer; Recurrent Renal Cell Cancer; Recurrent MelanomaLast Updated:March 4, 2024Completed
Condition(s):Breast Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic/Myeloproliferative DiseasesLast Updated:June 6, 2012Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:August 26, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.